Citations

Clear

421 citation(s) found for "Short, C".

Infantile Spasms and Injuries of Prematurity: Short-Term Treatment-Based Response and Long-Term Outcomes
Wallace, Adam, Allen, Victoria M. , Park, Kristen , Knupp, Kelly G.

Mayo Clinic

Journal of Child Neurology | June 21, 2017 | Volume: 32 | Issue: 10 | Pages: 861-866

10.1177/0883073817712587 | PMID 28635418 Get It

The association of infantile spasms and periventricular leukomalacia and/or intraventricular hemorrhage is well documented. Data regarding early treatment-based and long-term outcomes are limited. A retrospective chart review identified children with infantile spasms born prematurely (<37 weeks) with diagnoses of periventricular leukomalacia and/or intraventricular hemorrhage. Thirteen children were included. Median gestational age was 30 weeks and age of onset of infantile spasms was 8 months. Nine children had intraventricular hemorrhage, 10 had periventricular leukomalacia, and 6 children had both. Twelve of 13 children had resolution of spasms. In responders, the successful medication was adrenocorticotropic hormone (ACTH) in 7, topiramate in 3, and vigabatrin in 2. Follow-up after a median of 7.1 years found that all patients had developmental delay but only 1 had refractory epilepsy. Standard therapies (ACTH and vigabatrin) appeared to be more effective than other treatments. Developmental delay is common in children with periventricular leukomalacia / intraventricular hemorrhage and infantile spasms, but refractory epilepsy might be less frequent.
PS8-11 The Effect of Rotator Cuff Imbalance during Glenohumeral Abduction(PS8: Poster Short Presentation VIII,Poster Session)
Matsuhashi, Tomoya , Sperling, John W. , Steinmann, Scott P. , An, Kai‐Nan, Iwasaki, Norisama

Mayo Clinic

The Proceedings of the Asian Pacific Conference on Biomechanics : emerging science and technology in biomechanics | June 19, 2017 | Volume: 2015.8 | Pages: 363

10.1299/jsmeapbio.2015.8.363 Get It

Clinical commentary on ‘Aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder with recurrent short partial transverse myelitis and favorable prognosis: Two new cases’, by Wang et al.
Flanagan, Eoin P.

Mayo Clinic

Multiple Sclerosis Journal | June 5, 2017 | Volume: 23 | Issue: 14 | Pages: 1954-1955

10.1177/1352458517712867 | PMID 28580877 Get It

Total lumbar facetectomy without fusion: short and long term follow-up in a single surgeon series
Pichelmann, Mark A., Atkinson, John L. D., Fode-Thomas, Nicolee C., Yaszemski, Michael J.

Mayo Clinic

British Journal of Neurosurgery | April 24, 2017 | Volume: 31 | Issue: 5 | Pages: 531-537

10.1080/02688697.2017.1319905 | PMID 28436275 Get It

Short‐ and long‐term clinical predictors of pharmacological cardioversion of persistent atrial fibrillation by dofetilide: A retrospective cohort study of 160 patients
Virk, Hafeez Ul Hassan , Makkar, Nayani , Bastawrose, Joseph, Souvaliotis, Nektarios , Aziz, Joshua, Aziz, Emad F. , Hassan Virk, Hafeez Ul , Qureshi, Waqas T

Mayo Clinic

Clinical Cardiology | March 14, 2017 | Volume: 40 | Issue: 7 | Pages: 474-479

10.1002/clc.22680 | PMID 28295387 Get It

IntroductionDofetilide is a class III antiarrhythmic prescribed to cardiovert persistent atrial fibrillation (AF) to sinus rhythm (SR).HypothesisTo determine the clinical predictors of cardioversion and readmission in persistent AF patients on dofetilide.MethodsWe analyzed 160 patients with persistent AF who were started on dofetilide and followed for 1 year. We examined age, sex, race, hypertension, diabetes, smoking, dyslipidemia, CAD, left ventricular ejection fraction (LVEF), creatinine, BMI and concomitant use of calcium channel blockers (CCB), β‐blockers in a multivariable logistic regression model. We also examined the same predictors in Cox regression model for AF‐related readmission within 1 year of follow‐up.Results13.5% individuals did not convert to SR on dofetilide. 55.6% converted on the first dose and 83.1% converted by the fourth dose. In multivariable logistic models, dyslipidemia (OR: 2.4, CI: 1.12‐5.16) and LVEF (OR: 3.83,CI: 1.37‐10.8) were associated with failure to convert with the first dose. Female sex and LVEF also were associated with increased risk of failure to convert at all. Concomitant use of CCB associated with decreased risk of failure to convert to SR. In Cox proportional model, female sex, age <63 years and CAD were associated with increased AF readmission within 1 year.ConclusionsDyslipidemia and LVEF <40% were associated with failure to cardiovert after first dose, and female sex and LVEF 40% were related to failure to convert at all on dofetilide in persistent AF patients. After 1‐year follow‐up, female sex, known CAD, and age <63 years were associated with increased AF readmissions.
Myelitis in neuromyelitis optica spectrum disorder: The long and the short of it
Flanagan, Eoin P. , Weinshenker, Brian G. , Flanagan, E P , Weinshenker, Brian G

Mayo Clinic

Multiple Sclerosis Journal | March 6, 2017 | Volume: 23 | Issue: 3 | Pages: 360-361

10.1177/1352458517692888 | PMID 28260418 Get It

Characteristics of long- versus short-surviving patients (Pts): An analysis of the ARIES Observational Cohort Study (OCS) of bevacizumab (BV)-treated pts with metastatic colorectal cancer (mCRC).
Kozloff, Mark, Bendell, Johanna C. , Cohn, Allen Lee, Roach, Nancy, Flick, E. Dawn, Mun, Yong, Fish, Susan, Laeufle, R., Sommer, Nicolas, Hurwitz, Herbert I. , Grothey, Axel , Bekaii‐Saab, Tanios

Mayo Clinic

Journal of Clinical Oncology | February 24, 2017 | Volume: 33 | Issue: 3_suppl | Pages: 702-702

10.1200/jco.2015.33.3_suppl.702 Get It

702 Background: Median overall survival (OS) in mCRC has significantly improved over the past 20 yrs, but the observed range of OS in pts remains wide; a large percentage of pts have OS <1 yr or >4 yrs. ARIES was a prospective OCS conducted from 2006–2012 that evaluated outcomes in pts receiving BV + chemotherapy (CT) for mCRC in general clinical practice. The objective of this analysis is to examine clinical characteristics of pts with long vs short OS. Methods: This analysis included 1,417/1,550 first-line (1L) BV-treated mCRC pts who died or had complete follow-up on study. Long OS was defined as OS within the upper quartile of the analysis population (range 42–67 mos); short OS was defined as OS within the lower quartile (range 0.3–12 mos). Progression-free survival (PFS) was estimated using Kaplan-Meier methods. Pt and disease characteristics and treatment patterns were described using summary statistics. Results: Pt and disease characteristics are shown in the Table. Median PFS was 22.3 mos (95% CI, 19.9–23.3) vs. 4.9 mos (95% CI, 4.6–5.4), in the long-OS vs. short-OS groups. More pts with long OS received any second-line (2L) therapy (71% vs. 46%), and were exposed to 5-fluorouracil, oxaliplatin, and irinotecan throughout the course of their disease (53% vs. 32%) compared with pts with short OS. KRAS/BRAF mutation status was not collected. Conclusions: Pts with long OS had better baseline performance status, primary tumors more likely to have been resected, and were more likely to have received 2L CT. Additional analyses of detailed treatment patterns and safety are ongoing. Clinical trial information: NCT00388206. [Table: see text]
Contemporary treatment patterns and short-term outcomes in men with very high-risk prostate cancer.
Tosoian, Jeffrey J. , Sundi, Debasish , Chapin, Brian F. , Chappidi, Meera R. , Karnes, R. Jeffrey , Ross, Ashley E. , Antonarakis, Emmanuel S. , Alam, Ridwan , Glavaris, Stephanie A. , Pienta, Kenneth J , Tran, Phuoc T , Schaeffer, Edward M.

Mayo Clinic

Journal of Clinical Oncology | February 24, 2017 | Volume: 34 | Issue: 2_suppl | Pages: 103-103

10.1200/jco.2016.34.2_suppl.103 Get It

103 Background: Beginning in 2014, the National Comprehensive Cancer Network (NCCN) recognized very high-risk (VHR) prostate cancer (cT3b-T4, or primary Gleason pattern 5, or more than 4 biopsy cores with Gleason score 8-10, or multiple HR features) as a classification distinct from high-risk (HR) disease. Using prospectively collected institutional data, we describe contemporary treatment patterns and short-term outcomes in the VHR population. Methods: Men who underwent radical prostatectomy (RP) between January 2010 and June 2015 were identified using the Johns Hopkins RP database, and trends in management were compared across the study period. Pathological and short-term clinical outcomes were assessed in men with VHR cancer. Non organ-confined disease (NOCD) was defined as ≥ pT3 disease or lymph node positivity, persistent postoperative PSA as ≥ 0.2 ng/mL, and biochemical recurrence (BCR) as a PSA ≥ 0.2 ng/mL following an initial undetectable postoperative PSA. Results: During the study period, 4,954 men underwent RP, of which 161 (3.2%) men had VHR cancer at diagnosis. The annual proportion of men who underwent RP with VHR cancer increased over the study period (chronologically 1.8%, 1.0%, 3.3%, 4.1%, 5.6%, and 5.2%; p<0.001). Sixteen percent of men with VHR disease were enrolled in pre-surgical clinical trials, with an increase from 0% of men in 2010 to 19.1% in 2015 (p=0.11). At RP, 39% of the VHR cohort had seminal vesicle invasion, 26% had lymph node involvement, and a total of 74% had NOCD. Following surgery, 33% of men had PSA persistence, and 40% experienced either PSA persistence or BCR during follow-up (median 13.4 months). Of 136 men with at least one follow-up assessment, 15 (11.0%) developed metastasis; 33% of the cohort was treated with radiation therapy, 42% with androgen deprivation, and 15% with docetaxel. Conclusions: The VHR population carries the greatest risk of clinical progression following local treatment. Over the past five years, we have observed increasing surgical treatment and clinical trial enrollment at our institution. Continued assessment of post-operative interventions and outcomes will help to facilitate counseling and establish point estimates from which to power clinical trials.
Salvage brachytherapy and short-term androgen deprivation therapy for locally recurrent prostate cancer after external beam irradiation
Wong, W. , Buskirk, S.J., Karin, Putu Ayu Emmy Savitri , Schild, Steven E.

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 4788-4788

10.1200/jco.2005.23.16_suppl.4788 Get It

Systematic review with meta‐analysis: the impact of Clostridium difficile infection on the short‐ and long‐term risks of colectomy in inflammatory bowel disease
Law, Cindy C Y , Tariq, Raseen , Khanna, Sahil , Murthy, Sanjay K. , Law, C C Y , McCurdy, Jeffrey D , Tariq, Raseen

Mayo Clinic

Alimentary Pharmacology & Therapeutics | February 16, 2017 | Volume: 45 | Issue: 8 | Pages: 1011-1020

10.1111/apt.13972 | PMID 28206678 Get It

SummaryBackgroundClostridium difficile infection (CDI) is associated with increased mortality in inflammatory bowel disease (IBD), but the risk of colectomy is variable and has not been adequately studied.AimTo perform a systematic review and meta‐analysis to assess the impact of CDI on colectomy risk in IBD.MethodsMultiple databases were searched systematically for observational studies reporting colectomy risk in IBD, stratified by the presence of CDI, and the duration of follow‐up (short term 3 months, and long term at least 1 year). Weighted summary estimates were calculated using generalised inverse variance with random‐effects model. Study quality was assessed using the Newcastle–Ottawa scale.ResultsTwelve observational studies were identified and included 35 057 IBD patients with CDI, and 929 259 without CDI. CDI did not increase the short‐term colectomy risk in IBD patients overall (10 studies) (OR: 1.35; 95% CI: 0.68–2.67), or in patients with ulcerative colitis (nine studies) (OR: 1.20; 95% CI: 0.39–3.76). In contrast, CDI was associated with higher long‐term colectomy risk in patients with IBD overall (five studies) (OR: 2.23; 95% CI: 1.18–4.21), and in patients with ulcerative colitis (four studies) (OR: 2.96; 95% CI: 1.19–7.34). The results were stable in subgroups stratified by recruitment period, hospitalisation status and geographical location. All studies were at least of moderate quality. The results were limited in the ability to compare IBD severity and the type of anti‐microbial therapy.ConclusionBased on 12 observational studies with at least moderate quality, Clostridium difficile infection appears to increase colectomy risk in IBD in the long‐ but not short‐ term.